12:00 AM
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Cardiome, Correvio deal

Cardiome acquired cardiovascular company Correvio in a cash and stock deal. Correvio shareholders received 19.9% of Cardiome's outstanding shares, or about 2.5 million shares, valued at about $9.6 million based on Cardiome's close of $3.88 on Nov. 15, the last day of trading before the deal was announced. Cardiome will also pay $12 million in deferred...

Read the full 257 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >